Navaporn Worasilchai

7PUBLICATIONS
60CO-AUTHORS
Creative arts, media and communication curriculum and pedagogyCancer therapy (excl. chemotherapy and radiation therapy)Major global burdens of diseaseApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Epidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 11, 2025
Improved Survival in Vascular Pythiosis With Surgery and Azithromycin, Doxycycline, and Itraconazole Therapy: A Phase II Multicenter, Open-Label, Single-Arm Trial.

Pattama Torvorapanit, Navaporn Worasilchai, Kasama Manothummetha

|Oct 08, 2024
Candidemia Following Severe COVID-19 in Hospitalised and Critical Ill Patients: A Systematic Review and Meta-Analysis.

Karan Srisurapanont, Bhoowit Lerttiendamrong, Tanaporn Meejun

|Feb 05, 2024
Ex vivo observation of Pythium insidiosum-antigen treated neutrophils on three Pythium insidiosum strains isolated from vascular pythiosis patients.

Sadeep Medhasi, Apichaya Sriwarom, Nitipong Permpalung

|Jun 30, 2023
Attenuated immunogenicity of SARS-CoV-2 vaccines and risk factors in stem cell transplant recipients: a meta-analysis.

Tanaporn Meejun, Karan Srisurapanont, Kasama Manothummetha

|Dec 20, 2022
Immunogenicity of SARS-CoV-2 vaccines in patients with multiple myeloma: a systematic review and meta-analysis.

Nipat Chuleerarux, Kasama Manothummetha, Chatphatai Moonla

Pageof 2